IL195653A0 - Oral pharmaceutical composition of a poorly water-soluble active substance - Google Patents

Oral pharmaceutical composition of a poorly water-soluble active substance

Info

Publication number
IL195653A0
IL195653A0 IL195653A IL19565308A IL195653A0 IL 195653 A0 IL195653 A0 IL 195653A0 IL 195653 A IL195653 A IL 195653A IL 19565308 A IL19565308 A IL 19565308A IL 195653 A0 IL195653 A0 IL 195653A0
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
active substance
poorly water
oral pharmaceutical
soluble active
Prior art date
Application number
IL195653A
Other languages
English (en)
Original Assignee
Solvay Pharm Bv
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv, Panacea Biotec Ltd filed Critical Solvay Pharm Bv
Publication of IL195653A0 publication Critical patent/IL195653A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL195653A 2006-06-22 2008-12-02 Oral pharmaceutical composition of a poorly water-soluble active substance IL195653A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81557906P 2006-06-22 2006-06-22
IN1473DE2006 2006-06-22
EP06115881 2006-06-22
PCT/EP2007/056207 WO2007147873A1 (en) 2006-06-22 2007-06-21 Oral pharmaceutical composition of a poorly water-soluble active substance

Publications (1)

Publication Number Publication Date
IL195653A0 true IL195653A0 (en) 2009-09-01

Family

ID=38475974

Family Applications (1)

Application Number Title Priority Date Filing Date
IL195653A IL195653A0 (en) 2006-06-22 2008-12-02 Oral pharmaceutical composition of a poorly water-soluble active substance

Country Status (9)

Country Link
EP (1) EP2037890A1 (ja)
JP (1) JP2009541267A (ja)
KR (1) KR20090033246A (ja)
AU (1) AU2007263016A1 (ja)
CA (1) CA2654243A1 (ja)
EA (1) EA200970045A1 (ja)
IL (1) IL195653A0 (ja)
NO (1) NO20090265L (ja)
WO (1) WO2007147873A1 (ja)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1397160A1 (en) * 2001-04-30 2004-03-17 Shire Laboratories Inc. Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
TW200633713A (en) * 2004-12-23 2006-10-01 Solvay Pharm Bv Oral immediate release formulation of a poorly water-soluble active substance
WO2007054975A1 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders

Also Published As

Publication number Publication date
EP2037890A1 (en) 2009-03-25
WO2007147873A1 (en) 2007-12-27
KR20090033246A (ko) 2009-04-01
AU2007263016A1 (en) 2007-12-27
EA200970045A1 (ru) 2009-06-30
NO20090265L (no) 2009-01-22
JP2009541267A (ja) 2009-11-26
CA2654243A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
ZA200900345B (en) Preparation of pharmaceutical formulations
IL206159A0 (en) Oral pharmaceutical dosage forms
ZA200810164B (en) Sustained release pharmaceutical dosage form containing phenylphrine
ZA200707022B (en) A solid pharmaceutical dosage formulation
IL197204A0 (en) Pharmaceutical compositions containing a weakly basic drug and a timed pulsatile release coating
ZA200809002B (en) Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
EP1968554A4 (en) BIOADHESIVE MEDICATION FORMULATIONS FOR ORAL TRANSMUCOSAL ADMINISTRATION
IL215988A (en) A hydrophilic drug oral drug emulsion that transforms into a self-emulsifying micro emulsion and a method for making it
EP2112925A4 (en) SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
HUE063083T2 (hu) Nilotinibet vagy sóját tartalmazó gyógyszerészeti készítmények
ME01614B (me) Farmaceutska kompozicija snažnog hcv inhibitora za oralnu primjenu
AP2008004671A0 (en) Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
EP2011482A4 (en) SOLID PREPARATION FOR ORAL APPLICATION
EP2078731A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT
PL2059260T3 (pl) Kompozycja farmaceutyczna obejmująca hGH do dostarczania doustnego
GB0614586D0 (en) Pharmaceutical Formulation
EP2001400A4 (en) ORAL FORMULATIONS OF GLYCYL-2-METHYLPROLYL-GLUTAMATE
EP2062579A4 (en) SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING OPTICALLY STABLE RAMOSETRON
ZA200807486B (en) Medicament formulations comprising fluoroquinolones
EP2206519A4 (en) MEDICINAL PREPARATION FOR ORAL ADMINISTRATION
EP2012705A4 (en) PHARMACEUTICAL FORMULATIONS FOR IONTOPHORETIC ACTIVE INJECTION
IL198160A0 (en) Pharmaceutical formulations
PL1848439T3 (pl) Doustna formulacja o natychmiastowym uwalnianiu słabo rozpuszczalnej w wodzie substancji aktywnej
IL195726A0 (en) Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant
IL191922A0 (en) Pharmaceutical formulations of oxcarbazepine and methods for its preparation